McGroddy-Goetz Kathleen
- SEC CIK
- 0001814371
No open-market purchases or sales filed in the past year.
Current role at each company
- TNDM Tandem Diabetes Care IncDirectoras of May 22, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists McGroddy-Goetz Kathleen as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 19, 2023 (view filing) | Sep 15 | 4 days | McGroddy-Goetz KathleenDirector | PPurchase | +1.00K | $21.45 | +$21.4K | +12.5%9.03K after | |
| Mar 16, 2022 (view filing) | Mar 14 | 2 days | McGroddy-Goetz KathleenDirector | SSale | −405 | $106.00 | −$42.9K | −33.2%814 after |